New shot option for myasthenia gravis patients studied

NCT ID NCT05514873

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 20 times

Summary

This study looked at 26 adults with generalized myasthenia gravis who switched from an IV infusion to a daily shot of zilucoplan. The main goal was to see if the switch was safe and well-tolerated. Researchers also checked if symptoms stayed under control. The study was completed and provides information on a more convenient treatment option.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Mg0017 50076

    Columbus, Ohio, 43221, United States

  • Mg0017 50086

    Charlotte, North Carolina, 28207, United States

  • Mg0017 50099

    San Francisco, California, 94143, United States

  • Mg0017 50111

    Seattle, Washington, 98195-0001, United States

  • Mg0017 50304

    Dallas, Texas, 75390-8866, United States

  • Mg0017 50555

    Austin, Texas, 78759, United States

  • Mg0017 50556

    Chapel Hill, North Carolina, 27599, United States

  • Mg0017 50557

    O'Fallon, Illinois, 62269, United States

  • Mg0017 50559

    Los Angeles, California, 90095, United States

  • Mg0017 50564

    Scottsdale, Arizona, 85251, United States

  • Mg0017 50569

    Greenfield, Wisconsin, 53228, United States

  • Mg0017 50593

    Rancho Mirage, California, 92270, United States

Conditions

Explore the condition pages connected to this study.